Covid -19 Glycoprotein can be Modified by Adding Short Oligosaccharide or o-Polysaccharide Derived from E. coli Making Weakness or Lose of ACE-2 Attachment |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.14, No. 1)Publication Date: 2021-08-25
Authors : Abouelenin SA;
Page : 115-116
Keywords : Oligosaccharide; Manno-sidases; Demon-strates; Poor substrates; Production;
Abstract
SARS-CoV-2 is a highly contagious and mutant pathogen. The pathogenicity depends on glycosylated spike which attack different types of cells and tissues containing ACE2 receptors. Here blocking or modified SARS-COV-2 glycoprotein by oligosaccharide derived from colon bacteria (Microbiota) or synthetic oligosaccharide (13 monosaccharide units) may of value in changing or modifier the configuration structure of spike protein. Finally may viruses lose the first step to induce pathogenesis.
Other Latest Articles
- Military Sexual Assault |Biomedgrid
- Methanol Leaf Extract of Desmodium Velutinum (Wild.) D.C. and Acarbose Exhibit Additive Pharmacological Effects in Diabetic Wistar Rats |Biomedgrid
- Management of Opioid Abuse Epidemic by Introducing Complementary and Alternative Medicine |Biomedgrid
- THE MECHANICAL PERFORMANCE OF PARALLEL TDG BAMBOO LAMINATED COLUMNS (TDGLC)
- THE APPLICATION OF LINEAR REGRESSION AND ARTIFICIAL NEAURAL NETWORKS TO FORECAST THE AMOUNT OF ELECTRONIC WASTE IN THAILAND
Last modified: 2023-10-13 22:10:48